SIBN news

Latest 3 stories · newest Nov 2, 2026

SIBN

SI-BONE reported strong Q3 2026 revenue growth driven by volume gains and new product approvals, highlighting the company's performance as a leader in procedural spine solutions.

Earnings Nov 2, 2026 sentiment +0.50 SEC filing ↗

SIBN

SI-BONE Q2 2026 Revenue Up 15%, Adjusted EBITDA Turns Positive

SI-BONE reported 15.2% second-quarter revenue growth to $56.0 million, achieved positive adjusted EBITDA, and raised its 2026 outlook due to strong demand and improved reimbursement.

Earnings|Guidance Aug 3, 2026 sentiment 0.00 SEC filing ↗

SIBN

SI-BONE extends Santa Clara office lease through September 2026

SI-BONE amended its office lease at 471 El Camino Real in Santa Clara, extending the term by up to two months through September 2026. The extension provides operational continuity for the medical device company's headquarters location.

Other Jun 8, 2026 sentiment 0.00 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same SIBN feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/SIBN/newsSTART FREE